Our results depicted that inhibiting miR-429 downregulated HIF1A and VEGF protein expression in HESCs and knocking down HIF1AN could offset this effect, suggesting that the miR-429/HIF1AN axis might promote the HIF1A/VEGF pathway in HESCs, thereby contributing to EM development. The gene discussed is VEGFA; the disease is erythema multiforme.